Table 9

Logistic regression using arm (4-HPR versus placebo) as the dependent variable

Dependent variableVariableAdditional variableDegree of freedomParameter estimate for armSEWald χ2POdds ratio
6 months, intention to treat
4-HPR armNone1−0.850.721.380.240.43
4-HPR armGrade1−0.910.781.350.2450.40
4-HPR armHPV1−0.350.820.180.6710.70
4-HPR armLesion size10.000.860.001.001.00
4-HPR armOCP1−1.170.792.200.1380.31
4-HPR armSmoke1−0.760.790.930.3340.47
4-HPR armNo. of partners1−0.820.751.190.2760.44
4-HPR armSTD1−0.840.721.360.2440.43
6 months, considering crossover
4-HPR armNone1−0.410.780.270.6030.67
4-HPR armGrade1−0.550.810.460.4990.58
4-HPR armHPV1−0.350.820.180.6710.70
4-HPR armLesion size10.000.860.001.001.00
4-HPR armOCP1−0.610.840.520.4690.55
4-HPR armSmoke1−0.290.860.110.7370.75
4-HPR armNo. of partners1−0.300.820.140.7130.74
4-HPR armSTD1−0.350.790.190.6600.71
12 months, intention to treat
4-HPR armNone1−2.480.946.930.0090.08
4-HPR armGrade1−3.001.087.700.0060.05
4-HPR armHPV1−2.240.995.130.0240.11
4-HPR armLesion size1−2.500.996.390.0120.08
4-HPR armOCP1−3.471.287.310.0070.03
4-HPR armSmoke1−3.031.236.110.0130.05
4-HPR armNo. of partners1−2.360.966.000.0140.10
4-HPR armSTD1−2.72 a a 0.0080.07
12 months, considering crossover
4-HPR armNone1−2.710.977.790.0050.07
4-HPR armGrade1−3.051.078.040.0050.05
4-HPR armHPV1−2.391.005.740.0170.09
4-HPR armLesion size1−2.640.997.120.0080.07
4-HPR armOCP1−3.511.287.590.0060.03
4-HPR armSmoke1−3.151.226.660.0100.04
4-HPR armNo. of partners1−2.621.006.860.0090.07
4-HPR armSTD1−2.78 a a 0.0070.06
  • a These data were derived from LogXact, which does not produce a SE or the Wald χ2.